New drug innovation remained strong in 2020. The total of 53 drugs approved represented the second-highest number of approvals in more than two decades, a positive indicator of productivity in the pha...
Leer más“Although Gregory received cutting edge immunotherapies and targeted therapies, including CAR-T 19 and an allogeneic CAR-T, the disease was very aggressive, and he succumbed to cancer,” explained ...
Leer másAs chemical and life science companies seeking to monetize their IP portfolios emerge from the challenges of COVID-19, 2021 looks to be a year that will see increased product licensing, acquisitions a...
Leer másA complete integrated freeze-drying system designed for high value anticancer products consisting of a reduced foot-print freeze dryer with an innovative loading/unloading system, integrating a steam-...
Leer másThe theranostic and genomic company signs subcontract service agreement with HalioDx’s CLIA-certified laboratory in Richmond, Virginia
Leer másAmerican Hospital of Paris and OncoDNA announced a new joint initiative that is intended to advance the use of precision medicine in routine clinical practice for patients with metastatic breast cance...
Leer másTelstar’s cutting-edge technologies and integrated process equipment & systems covering all the critical phases of the oncology production are designed according to the higher requirements of qualit...
Leer másOncoDNA SA has become the first shareholder of IntegraGen SA (Paris: ALINT), holding 29.99% of the existing shares, as result of purchases of shares on the Euronext Growth market .
Leer másThis transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both c...
Leer másBoehringer Ingelheim has acquired two preclinical antibodies from Canadian firm Northern Biologics with the aim of further strengthening its global position in cancer immunology.
Leer másThe consortium is bringing together a unique group of microbiologists, cancer biologists, chemists, material scientists, mechanical engineers, ocular pharmacologists, geneticists and toxicologists fro...
Leer más